• OPEN AN ACCOUNT
Indian Indices
Nifty
25,149.85 -205.40
(-0.81%)
Sensex
82,500.47 -689.81
( -0.83%)
Bank Nifty
56,754.70 -201.30
( -0.35%)
Nifty IT
37,693.25 -683.40
( -1.78%)
Global Indices
Nasdaq
44,384.39 -287.26
(-0.64%)
Dow Jones
6,279.98 -21.48
(-0.34%)
Hang Seng
39,553.98 -92.38
(-0.23%)
Nikkei 225
8,941.12 -34.54
(-0.38%)
Forex
USD-INR
85.68 -0.05
(-0.06%)
EUR-INR
100.36 -0.05
(-0.05%)
GBP-INR
116.41 -0.07
(-0.06%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Triochem Products Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
512101
INE331E01013
557.8326531
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
0.43
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Unjha Formulations reports standalone net loss of Rs 0.41 crore in the March 2025 quarter
May 17,2025
Net Loss of Unjha Formulations reported to Rs 0.41 crore in the quarter ended March 2025 as against net loss of Rs 0.18 crore during the previous quarter ended March 2024. Sales declined 46.50% to Rs 2.37 crore in the quarter ended March 2025 as against Rs 4.43 crore during the previous quarter ended March 2024.

For the full year,net profit rose 46.43% to Rs 0.41 crore in the year ended March 2025 as against Rs 0.28 crore during the previous year ended March 2024. Sales declined 25.08% to Rs 13.86 crore in the year ended March 2025 as against Rs 18.50 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales2.374.43 -47 13.8618.50 -25
OPM %-13.921.35 -3.823.19 -
PBDT-0.260.02 PL 0.630.54 17
PBT-0.290 0 0.530.46 15
NP-0.41-0.18 -128 0.410.28 46